CombiMatrix Corp.
(NASDAQ : CBMX)

( )
CBMX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.87%285.761.5%$877.84m
GILDGilead Sciences, Inc. -0.19%87.791.0%$684.30m
MRNAModerna, Inc. 3.15%179.000.0%$651.73m
REGNRegeneron Pharmaceuticals, Inc. 2.25%764.272.6%$499.64m
VRTXVertex Pharmaceuticals, Inc. 1.85%317.581.9%$473.10m
BIIBBiogen, Inc. 0.23%292.151.8%$407.81m
ILMNIllumina, Inc. 1.23%208.523.2%$225.94m
BMRNBioMarin Pharmaceutical, Inc. 1.44%103.694.2%$162.19m
BNTXBioNTech SE 0.63%162.630.0%$150.70m
AXSMAxsome Therapeutics, Inc. 3.85%78.161.6%$146.95m
SNSSSunesis Pharmaceuticals, Inc. -3.98%1.930.7%$134.91m
RXDXPrometheus Biosciences, Inc 165.67%95.801.4%$103.84m
MRTXMirati Therapeutics, Inc. -30.66%49.591.6%$102.08m
HALOHalozyme Therapeutics, Inc. 2.41%57.7418.4%$82.03m
NVAXNovavax, Inc. 2.62%17.2275.3%$81.88m

Company Profile

CombiMatrix Corporation develops proprietary technologies, products, and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology, and defense and homeland security. Its technologies include a platform to produce user-defined, in-situ synthesized, and oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations, and proteins. The company�s products and services include CustomArray platform, an oligonucleotide array for genetic studies; DNA Array Synthesizer, an instrument that enables researchers to fabricate DNA arrays to their specifications; stripping reagents, which enable researchers to re-use microarrays; ElectraSense Reader, an electrochemical scanning instrument; and comparative genomic hybridization arrays, which are used for research and molecular diagnostic applications. It also offers proprietary molecular synthesis and screening methods for the discovery of potential new drugs. In addition, it operates as a diagnostics reference laboratory, which provides genetic diagnostics services through the use of arrays that utilize bacterial artificial chromosomes that enable genetic analysis to physicians, hospitals, and clinics. Further, the company develops a series of compounds to address various oncology-related diseases. Additionally, it involves in the development, manufacture, and sale of biosensor systems and technology for national defense and homeland security. The company sells its products and services directly, with partners, and through distributors to customers in the United States, Europe, and Asia. CombiMatrix Corporation was founded in 1995 and is based in Mukilteo, Washington.